Physician profile
Ning Ning
NPI 1356704662
$123,609.50
in general payments reported to CMS, 2019-2025
13 companies · $1,076 in 2025
The $1,076 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,268 · 2023: $115K · 2024: $3,576 · 2025: $1,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $111K · Food and Beverage: $5,029 · Travel and Lodging: $3,812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $110,500.00 |
| Food and Beverage | $5,029.33 |
| Travel and Lodging | $3,812.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $87,720.71 | 2022-2025 | Ranger, Emerge Push, Avvigo Guidance System |
| Abbott Laboratories | $23,577.19 | 2023-2024 | Optis, Diamondback Coronary, Ultreon |
| Medtronic, INC. | $8,955.17 | 2023-2025 | Symplicity G3 |
| Shockwave Medical, INC | $1,278.35 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $1,031.25 | 2023-2024 | Indigo System, Penumbra System |
| Abiomed | $359.00 | 2024-2025 | Impella |
| Philips North America LLC | $159.62 | 2024 | (Bq9) Coronary Ivus |
| Cardiovascular Systems INC. | $148.00 | 2022 | |
| Biotronik INC. | $114.70 | 2024 | |
| Cardiva Medical, INC. | $112.01 | 2022 | |
| Heartflow, INC. | $96.29 | 2023 | Ffrct |
| Terumo Medical Corporation | $42.56 | 2023 | Optitorque |
| Edwards Lifesciences Corporation | $14.65 | 2023 | Sapien 3 Ultra Resilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ning Ning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.